Takeda Expands Antibody Collaboration With Xoma

Agreement now could earn California company $230 million before royalties for identifying therapeutic antibodies that target cancer.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet